Epiretinal membrane development after Ex-Press glaucoma filtration device implant: 2-year results of a case control study.

"Declarations Conflict of interestThe authors declare that they have no competing interests. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript. Ethical approvalAll experimental protocols were approved by the institutional ethical committee of University of Pisa (CEAVNO Comitato Etico Area Vasta Nordovest, register number: 16554-Casini). All procedures performed in studies involving human participants were in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Consent for publicationNot applicable. Informed consentWritten informed consent was obtained from all subjects included in the study. Conflict of interest The authors declare that they have no competing interests. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript."

"Funding Open access funding provided by Università di Pisa within the CRUI-CARE Agreement. No funding was received for this research."